De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT05134779
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Live Biobank — PROCEDURE
    Tumor tissue will be collected from consented patients at sequential inflection points in the disease course: at the time of initial diagnosis, at the time of surgery and during recurrence or metastasis. In addition to this, 40ml of research bloods will also be collected at these key inflection points.

Study Details

This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.

Key Dates

Start date
Jan 12, 2022
Status verified
Dec 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Cohort 1
    Patients with breast cancer (BC), any stage will be considered for this study.

Primary Outcome Measure

establish a live biobank for breast cancer patients [ Time Frame: 60 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Brooklyn Methodist Hospital - NewYork PresbyterianNew YorkNew York11215
Izael Niño, M.S.
[email protected]
929-470-9426
Hani Ashamalla, M.D. (PRINCIPAL_INVESTIGATOR)
New York Presbyterian Hospital - QueensNew YorkNew York11355
Hina Ali, M.D.
[email protected]
Akkamma Ravi, M.D. (SUB_INVESTIGATOR)
Silvia Formenti, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Brooklyn Methodist Hospital - NewYork Presbyterian· New York, NYNew York Presbyterian Hospital - Queens· New York, NY

Related Studies